← Back to Search

Digital Cancer Care System for Mental Illness and Cancer

N/A

Recruiting

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 weeks from study enrollment

Awards & highlights

Study Summary

This trial studies a digital cancer care system for people with serious mental illness and cancer, to improve care and manage psychiatric symptoms.

Who is the study for?

This trial is for adults over 18 with serious mental illness (like schizophrenia, bipolar disorder, or major depression) who also have a new diagnosis of stage I-IV breast, lung, gastrointestinal, genitourinary, or head and neck cancer. They must speak English fluently and be recently referred to MGH Danvers for oncology consultation.Check my eligibility

What is being tested?

The study is testing the effectiveness of a virtual tumor board that addresses both cancer and mental health issues. It aims to see if this approach helps in patient care management, reduces psychiatric symptoms, and boosts clinician confidence in treating these patients.See study design

What are the potential side effects?

Since this trial involves a non-medical intervention focusing on care coordination rather than direct treatment, traditional physical side effects are not expected. However, participants may experience changes in stress levels due to discussions about their conditions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 weeks from study enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 weeks from study enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks from study enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient enrollment assessed by consent rate.

Patient satisfaction assessed by patient feedback questionnaire.

Patient trial completion assessed by number of patients who complete study assessments and trial procedures.

Secondary outcome measures

Number of participants contributing to multi-disciplinary representation at tumor board sessions.

Percentage of tumor board participants completing study questionnaires.

Percentage of tumor board participants participating in tumor board session.

+3 more

Other outcome measures

Change in patient anxiety symptoms assessed by the Generalized Anxiety Disorder-7 (GAD-7).

Change in patient depression symptoms assessed by Patient Health Questionnaire-9 (PHQ-9).

Change in patient psychiatric illness severity assessed by Brief Psychiatric Rating Scale (BPRS).

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Tumor Board ArmExperimental Treatment1 Intervention

This intervention has three parts: Part 1: Proactive identification and assessment of patient needs, values, psychiatric symptoms, and illness understanding Part 2: Virtual tumor board discussion o Bring together expertise in mental illness and cancer, the interdisciplinary team will co-design an integrated cancer and mental health treatment plan. Key strategies include: addressing resource-related barriers to care, framing next steps in terms of patient values, and identifying action steps to address barriers to psycho-oncology/specialty oncology expertise Part 3: Closed Loop Communication o Tumor board recommendations shared with treating oncologist, documented in medical record, and shared with patient. Team tracks steps taken to address barriers to care and follows up with patient at 12 weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Trefler FoundationUNKNOWN

Massachusetts General HospitalLead Sponsor

2,935 Previous Clinical Trials

13,198,611 Total Patients Enrolled

45 Trials studying Schizophrenia

6,976 Patients Enrolled for Schizophrenia

Media Library

Schizophrenia Research Study Groups: Tumor Board Arm

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining in this experiment for volunteers?

"Confirmed, clinicaltrials.gov reveals that this investigation is still enrolling individuals. The trial was initially posted on May 31st 2023 and the most recent update appears to have been made on August 1st of the same year."

Answered by AI

What is the overall participation rate in this clinical experiment?

"Affirmative. Clinicaltrials.gov states that this trial is still recruiting, having been initially posted on May 31st 2023 and last updated on August 1st of the same year. They are looking for 30 volunteers based at a single clinical site."

Answered by AI

What key goals is this research seeking to accomplish?

"As the primary outcome, this clinical trial will document patient contentment by way of questionnaires over 12 weeks. Additionally, secondary objectives include ascertaining the program feasibility through completion of study measures (at least 70% of participants completing 12-week and 24-week assessments), evaluating multi-disciplinary representation at tumor board sessions (>70% including oncology/cancer center affiliate, community mental health, and psycho-oncology), and assessing participant intervention satisfaction regarding virtual tumour board model acceptability via an in session questionnaire."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Adapting the Tumor Board Model for Mental Illness and Cancer

Kelly Edwards Irwin 2023. "Adapting the Tumor Board Model for Mental Illness and Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05837598.

All > Mental Illness > Bipolar Disorder